NCT04268654

Brief Summary

This study is a randomized clinical trial to clarify if preoperative embolization of gastric arteries can reduce the incidence of oesophagogastric leakage after an esophagectomy for esophageal cancer comparing an experimental group vs control group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 13, 2017

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

February 6, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 13, 2020

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

January 21, 2022

Status Verified

November 1, 2021

Enrollment Period

4.5 years

First QC Date

February 6, 2020

Last Update Submit

January 19, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Anastomotic leakage

    Clinic, endoscopy or computed tomography with oral contrast of dehiscence of oesophagogastric anastomosis.

    90 days

Secondary Outcomes (6)

  • Tissue pressure oxygen (Ptio2)

    48 hours

  • Relation between PtiO2 and anastomotic leakage

    90 days

  • Gastric Conduit ischemia

    90 days

  • Morbidity

    90 days

  • Mortality

    90 days

  • +1 more secondary outcomes

Study Arms (2)

Ischemic Conditioning

EXPERIMENTAL

Preoperative artery embolization prior to esophagectomy Tissue pressure of oxygen measurement in both arms by Licox system. The probe is inserted directly through the skin as a cervical drainage and it is fixed by Witzel technique in the gastric conduit. It is removed after the three measurements (intraoperatively, 24h and 48h after surgery) of the PtiO2 as a normal drainage.

Procedure: Preoperative Arterial Embolization

Control

NO INTERVENTION

Surgery without previous ischemic conditioning of the gastric conduit Tissue pressure of oxygen measurement in both arms by Licox system. The probe is inserted directly through the skin as a cervical drainage and it is fixed by Witzel technique in the gastric conduit. It is removed after the three measurements (intraoperatively, 24h and 48h after surgery) of the PtiO2 as a normal drainage.

Interventions

PAE will be performed by arteriographic procedure before esophageal resection surgery minimum 14 days before surgery. An angiogram of the celiac trunk is performed through a femoral access before and after the embolization. Embolization by coils of the left gastric artery, splenic artery and the right gastric artery is realized.

Ischemic Conditioning

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients requiring a esophagectomy with cervical esophagogastrostomy for esophageal cancer
  • or above years old
  • Karnofsky\>50%
  • Acceptance and signing the full informed consent

You may not qualify if:

  • Fistula tracheobronchial
  • Metastatic disease
  • Anatomic vascular alteration that contraindicate the embolization (congenital celiac trunk stenosis, presence of arcuate ligament, atherosclerotic stenosis, etc,..)
  • Severe cardiorespiratory failure
  • Refuse to collaborate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Clínico Universitario de Valencia

Valencia, VAL, 46010, Spain

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 6, 2020

First Posted

February 13, 2020

Study Start

June 13, 2017

Primary Completion

December 1, 2021

Study Completion

December 1, 2021

Last Updated

January 21, 2022

Record last verified: 2021-11

Locations